Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 13/20 | 0.81 |
| ▸ | PNP | P00491 | 6/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.72 |
| ▸ | POLA1 | P09884 | 1/20 | 0.69 |
| ▸ | POLG | P54098 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gs-438 SCHEMBL64567 | 0.90 | POLB (0.80) | HPRT1PNPPOLBPOLA1POLG | |
| SCHEMBL23859843 | 0.90 | HPRT1 (1.00) | HPRT1PNPPOLG | |
| SCHEMBL16625352 | 0.87 | HPRT1 (0.64) | HPRT1PNPPOLB | |
| SCHEMBL2346358 | 0.87 | PNP (0.79) | HPRT1PNPPOLBPOLA1POLG | |
| Gs-438 SCHEMBL3497651 | 0.86 | POLB (0.84) | HPRT1PNPPOLBPOLA1POLG | |
| SCHEMBL2734697 | 0.85 | POLB (0.77) | HPRT1PNPPOLBPOLA1POLG | |
| SCHEMBL10430808 | 0.84 | PNP (0.71) | HPRT1PNPPOLBPOLA1POLG | |
| SCHEMBL9515948 | 0.84 | PNP (1.00) | HPRT1PNP | |
| SCHEMBL9055784 | 0.84 | POLB (0.81) | HPRT1PNPPOLBPOLA1POLG | |
| SCHEMBL24721833 | 0.84 | POLB (0.74) | HPRT1PNPPOLBPOLA1POLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731699-A1 | POLYMER | The Texas A&M University System (US) | 2026-04-29 | — | — | EP | claimed |
| US-12472304-B2 | Adaptive neuro-fuzzy inference system for closed loop total intravenous anesthesia management | SMARTTIVA INC (US) | 2025-11-18 | — | — | US | claimed |
| US-20250319253-A1 | Adaptive Neuro-Fuzzy Inference System for closed loop Total Intravenous Anesthesia Management | SMARTTIVA INC (US) | 2025-10-16 | — | — | US | claimed |
| US-20250002646-A1 | POLYMER | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-01-02 | — | — | US | claimed |
| WO-2024263862-A1 | POLYMER | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2024-12-26 | — | — | WO | claimed |
| CN-118834265-A | Polypeptide with complement inhibition activity, fusion protein and medical application thereof | 北京拓界生物医药科技有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118266873-A | Anesthesia state detection method, anesthesia state detection system, storage medium and anesthesia state detection equipment | 上海岩思类脑人工智能研究院有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-112435741-B | Sleep-aiding system using sleep latency database | 杭州云睡吧健康管理有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113951896-A | Brain-computer interface decoding method based on intracranial brain electricity and scalp brain electricity fusion | 之江实验室 | 2022-01-21 | — | — | CN | claimed |
| EP-4731699-A1 | POLYMER | The Texas A&M University System (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20250352656-A1 | SYNTHETIC CATIONIC PEPTIDOMIMETICS, THEIR DERIVATIVES AND PREPARATION THEREOF ALONG WITH COMPOSITIONS FOR VARIOUS MEDICAL APPLICATIONS | PEPTOMER THERAPEUTICS PRIVATE LTD (IN) | 2025-11-20 | — | — | US | disclosed |
| US-12472304-B2 | Adaptive neuro-fuzzy inference system for closed loop total intravenous anesthesia management | SMARTTIVA INC (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250319253-A1 | Adaptive Neuro-Fuzzy Inference System for closed loop Total Intravenous Anesthesia Management | SMARTTIVA INC (US) | 2025-10-16 | — | — | US | disclosed |
| EP-4525827-A1 | SYNTHETIC CATIONIC PEPTIDOMIMETICS, THEIR DERIVATIVES AND PREPARATION THEREOF ALONG WITH COMPOSITIONS FOR VARIOUS MEDICAL APPLICATIONS | Peptomer Therapeutics Private Limited (IN) | 2025-03-26 | — | — | EP | disclosed |
| EP-2847201-B1 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | UNIV QUEENSLAND (AU) | 2017-08-16 | — | — | EP | disclosed |
| WO-2017100849-A1 | 6-OXOPURINE PHOSPHORIBOSYL TRANSFERASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-06-22 | — | — | WO | disclosed |
| US-9200020-B2 | 6-oxopurine phosphoribosyltransferase inhibitors | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-12-01 | — | — | US | disclosed |
| US-20150099722-A1 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-04-09 | — | — | US | disclosed |
| EP-2847201-A2 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | The University of Queensland (AU) | 2015-03-18 | — | — | EP | disclosed |
| WO-2013166545-A2 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352656-A1 | SYNTHETIC CATIONIC PEPTIDOMIMETICS, THEIR DERIVATIVES AND PREPARATION THEREOF ALONG WITH COMPOSITIONS FOR VARIOUS MEDICAL APPLICATIONS | NOD2, NGLY1, CGAS | HPRT1 818/4885PNP 1227/4885POLB 3084/4885 |
| US-20150099722-A1 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | HPRT1, APRT, TPMT | HPRT1 1/4885PNP 11/4885POLB 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.